相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Excess TGF-β mediates muscle weakness associated with bone metastases in mice
David L. Waning et al.
NATURE MEDICINE (2015)
Matrix protein CCN1 induced by bacterial DNA and CpG ODN limits lung inflammation and contributes to innate immune homeostasis
H-G Moon et al.
MUCOSAL IMMUNOLOGY (2015)
RANK-ligand (RANKL) expression in young breast cancer patients and during pregnancy
Hatem A. Azim et al.
BREAST CANCER RESEARCH (2015)
The Role of Denosumab for Prevention of Skeletal-Related Complications in Multiple Myeloma
Kelly Hageman et al.
ANNALS OF PHARMACOTHERAPY (2013)
Novel 6-aminofuro[3,2-c]pyridines as potent, orally efficacious inhibitors of cMET and RON kinases
Arno G. Steinig et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
Hck contributes to bone homeostasis by controlling the recruitment of osteoclast precursors
Christel Verollet et al.
FASEB JOURNAL (2013)
Inhibition of Ron Kinase Blocks Conversion of Micrometastases to Overt Metastases by Boosting Antitumor Immunity
Henok Eyob et al.
CANCER DISCOVERY (2013)
Impact of Docosahexaenoic Acid on Gene Expression during Osteoclastogenesis in Vitro-A Comprehensive Analysis
Masako Akiyama et al.
NUTRIENTS (2013)
Possible survival benefits from zoledronic acid treatment in patients with bone metastases from solid tumours and poor prognostic features-An exploratory analysis of placebo-controlled trials
Robert E. Coleman et al.
JOURNAL OF BONE ONCOLOGY (2013)
Patient-derived luminal breast cancer xenografts retain hormone receptor heterogeneity and help define unique estrogen-dependent gene signatures
Peter Kabos et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Elucidating Prognosis and Biology of Breast Cancer Arising in Young Women Using Gene Expression Profiling
Hatem A. Azim et al.
CLINICAL CANCER RESEARCH (2012)
Superiority of denosumab to zoledronic acid for prevention of skeletal-related events: A combined analysis of 3 pivotal, randomised, phase 3 trials
Allan Lipton et al.
EUROPEAN JOURNAL OF CANCER (2012)
Efficacy and Safety of Denosumab for the Treatment of Bone Metastases in Patients with Advanced Cancer
Takayasu Kurata et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2012)
Five years of denosumab exposure in women with postmenopausal osteoporosis: Results from the first two years of the FREEDOM extension
Socrates Papapoulos et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2012)
c-Src Links a RANK/αvβ3 Integrin Complex to the Osteoclast Cytoskeleton
Takashi Izawa et al.
MOLECULAR AND CELLULAR BIOLOGY (2012)
New developments in osteoimmunology
Hiroshi Takayanagi
NATURE REVIEWS RHEUMATOLOGY (2012)
Tumor-Derived Jagged1 Promotes Osteolytic Bone Metastasis of Breast Cancer by Engaging Notch Signaling in Bone Cells
Nilay Sethi et al.
CANCER CELL (2011)
Src Kinase Mediates Productive Endocytic Sorting of Reovirus during Cell Entry
Bernardo A. Mainou et al.
JOURNAL OF VIROLOGY (2011)
Cancer to bone: a fatal attraction
Katherine N. Weilbaecher et al.
NATURE REVIEWS CANCER (2011)
Combined therapy with the RANKL inhibitor RANK-Fc and rhApo2L/TRAIL/dulanermin reduces bone lesions and skeletal tumor burden in a model of breast cancer skeletal metastasise
Pamela M. Holland et al.
CANCER BIOLOGY & THERAPY (2010)
Metastasis and bone loss: Advancing treatment and prevention
Robert E. Coleman et al.
CANCER TREATMENT REVIEWS (2010)
The Macrophage Stimulating Protein/Ron Pathway as a Potential Therapeutic Target to Impede Multiple Mechanisms Involved in Breast Cancer Progression
Kelsi L. Kretschmann et al.
CURRENT DRUG TARGETS (2010)
Bone histomorphometry: Standardization of nomenclature, symbols, and units: Report of the asbmr histomorphometry nomenclature committee
A. Michael Parfitt et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Fyn Promotes Proliferation, Differentiation, Survival and Function of Osteoclast Lineage Cells
Hyun-Ju Kim et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2010)
Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind Study
Alison T. Stopeck et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Lyn inhibits osteoclast differentiation by interfering with PLCγ1-mediated Ca2+ signaling
Soo-Hyun Yoon et al.
FEBS LETTERS (2009)
Discovery of N-(4-(2-Amino-3-chloropyridin-4-yloxy)-3-fluorophenyl)-4-ethoxy-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide (BMS-777607), a Selective and Orally Efficacious Inhibitor of the Met Kinase Superfamily
Gretchen M. Schroeder et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
Steven R. Cummings et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
The Src family kinase, Lyn, suppresses osteoclastogenesis in vitro and in vivo
Hyun-Ju Kim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Functional grouping of osteoclast genes revealed through microarray analysis
Guozhe Yang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Inhibition of RANKL blocks skeletal tumor progression and improves survival in a mouse model of breast cancer bone metastasis
Jude R. Canon et al.
CLINICAL & EXPERIMENTAL METASTASIS (2008)
The macrophage-stimulating protein pathway promotes metastasis in a mouse model for breast cancer and predicts poor prognosis in humans
Alana L. Welm et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
EGFR and Src are involved in indole-3-carbinol-induced death and cell cycle arrest of human breast cancer cells
Elena P. Moiseeva et al.
CARCINOGENESIS (2007)
Mammary-specific Ron receptor overexpression induces highly metastatic mammary tumors associated with β-catenin activation
Glendon M. Zinser et al.
CANCER RESEARCH (2006)
Effect of conditional knockout of the type II TGF-β receptor gene in mammary epithelia on mammary gland development and polyomavirus middle T antigen induced tumor formation and metastasis
E Forrester et al.
CANCER RESEARCH (2005)
Fracture risk with multiple myeloma: A population-based study
LJ Melton et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2005)
Future directions in the treatment and prevention of bone metastases
RE Coleman
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2002)
Tumour cells produce receptor activator of NF-κB ligand (RANKL) in skeletal metastases
L Huang et al.
JOURNAL OF CLINICAL PATHOLOGY (2002)
Ron-mediated cytoplasmic signaling is dispensable for viability but is required to limit inflammatory responses
SE Waltz et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
分享论文
